145 related articles for article (PubMed ID: 10375692)
1. Scatter factor/hepatocyte growth factor gene transfer increases rat blood-glioma barrier permeability.
Book AA; Ranganathan S; Abounader R; Rosen E; Laterra J
Brain Res; 1999 Jul; 833(2):173-80. PubMed ID: 10375692
[TBL] [Abstract][Full Text] [Related]
2. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.
Laterra J; Nam M; Rosen E; Rao JS; Lamszus K; Goldberg ID; Johnston P
Lab Invest; 1997 Apr; 76(4):565-77. PubMed ID: 9111517
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor/scatter factor (HGF/SF) induces vascular permeability factor (VPF/VEGF) expression by cultured keratinocytes.
Gille J; Khalik M; König V; Kaufmann R
J Invest Dermatol; 1998 Dec; 111(6):1160-5. PubMed ID: 9856833
[TBL] [Abstract][Full Text] [Related]
4. Scatter factor/hepatocyte growth factor (SF/HGF) content and function in human gliomas.
Lamszus K; Laterra J; Westphal M; Rosen EM
Int J Dev Neurosci; 1999; 17(5-6):517-30. PubMed ID: 10571413
[TBL] [Abstract][Full Text] [Related]
5. Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis.
Schmidt NO; Westphal M; Hagel C; Ergün S; Stavrou D; Rosen EM; Lamszus K
Int J Cancer; 1999 Feb; 84(1):10-8. PubMed ID: 9988225
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of vascular endothelial growth factor induced by hepatocyte growth factor/scatter factor stimulation in human glioma cells.
Moriyama T; Kataoka H; Hamasuna R; Yokogami K; Uehara H; Kawano H; Goya T; Tsubouchi H; Koono M; Wakisaka S
Biochem Biophys Res Commun; 1998 Aug; 249(1):73-7. PubMed ID: 9705834
[TBL] [Abstract][Full Text] [Related]
7. In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis.
Abounader R; Lal B; Luddy C; Koe G; Davidson B; Rosen EM; Laterra J
FASEB J; 2002 Jan; 16(1):108-10. PubMed ID: 11729097
[TBL] [Abstract][Full Text] [Related]
8. Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways.
Bowers DC; Fan S; Walter KA; Abounader R; Williams JA; Rosen EM; Laterra J
Cancer Res; 2000 Aug; 60(15):4277-83. PubMed ID: 10945642
[TBL] [Abstract][Full Text] [Related]
9. Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid: the key to angiogenesis?
Weindel K; Moringlane JR; Marmé D; Weich HA
Neurosurgery; 1994 Sep; 35(3):439-48; discussion 448-9. PubMed ID: 7528359
[TBL] [Abstract][Full Text] [Related]
10. Increased Sp1 phosphorylation as a mechanism of hepatocyte growth factor (HGF/SF)-induced vascular endothelial growth factor (VEGF/VPF) transcription.
Reisinger K; Kaufmann R; Gille J
J Cell Sci; 2003 Jan; 116(Pt 2):225-38. PubMed ID: 12482909
[TBL] [Abstract][Full Text] [Related]
11. Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression.
Abounader R; Ranganathan S; Lal B; Fielding K; Book A; Dietz H; Burger P; Laterra J
J Natl Cancer Inst; 1999 Sep; 91(18):1548-56. PubMed ID: 10491431
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor.
Heiss JD; Papavassiliou E; Merrill MJ; Nieman L; Knightly JJ; Walbridge S; Edwards NA; Oldfield EH
J Clin Invest; 1996 Sep; 98(6):1400-8. PubMed ID: 8823305
[TBL] [Abstract][Full Text] [Related]
13. Expression of hepatocyte growth factor/scatter factor and c-Met in human dental papilla and fibroblasts from dental papilla.
Kajihara T; Ohnishi T; Arakaki N; Semba I; Daikuhara Y
Arch Oral Biol; 1999 Feb; 44(2):135-47. PubMed ID: 10206332
[TBL] [Abstract][Full Text] [Related]
14. Co-expression of VEGF, c-Met and HGF/SF in secondary pleural tumors.
Naim R; Tolnay E; Mueller KM; Kuhnen C
Int J Mol Med; 2004 Nov; 14(5):787-91. PubMed ID: 15492846
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor-stimulated renal tubular mitogenesis: effects on expression of c-myc, c-fos, c-met, VEGF and the VHL tumour-suppressor and related genes.
Clifford SC; Czapla K; Richards FM; O'Donoghue DJ; Maher ER
Br J Cancer; 1998 May; 77(9):1420-8. PubMed ID: 9652757
[TBL] [Abstract][Full Text] [Related]
16. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
Kataoka H; Hamasuna R; Itoh H; Kitamura N; Koono M
Cancer Res; 2000 Nov; 60(21):6148-59. PubMed ID: 11085539
[TBL] [Abstract][Full Text] [Related]
17. Expression of hepatocyte growth factor/scatter factor and its receptor c-Met in brain tumors: evidence for a role in progression of astrocytic tumors (Review).
Moriyama T; Kataoka H; Koono M; Wakisaka S
Int J Mol Med; 1999 May; 3(5):531-6. PubMed ID: 10202187
[TBL] [Abstract][Full Text] [Related]
18. In vitro modulation of microglia motility by glioma cells is mediated by hepatocyte growth factor/scatter factor.
Badie B; Schartner J; Klaver J; Vorpahl J
Neurosurgery; 1999 May; 44(5):1077-82; discussion 1082-3. PubMed ID: 10232541
[TBL] [Abstract][Full Text] [Related]
19. Expression and localization of scatter factor/hepatocyte growth factor in human astrocytomas.
Kunkel P; Müller S; Schirmacher P; Stavrou D; Fillbrandt R; Westphal M; Lamszus K
Neuro Oncol; 2001 Apr; 3(2):82-8. PubMed ID: 11296484
[TBL] [Abstract][Full Text] [Related]
20. Glioma inhibition by HGF/NK2, an antagonist of scatter factor/hepatocyte growth factor.
Guerin C; Luddy C; Abounader R; Lal B; Laterra J
Biochem Biophys Res Commun; 2000 Jun; 273(1):287-93. PubMed ID: 10873600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
